How elevated oxalate can promote kidney stone disease: Changes at the surface and in the cytosol of renal cells that promote crystal adherence and growth

Frontiers in Bioscience

Volumn 9, Issue , 2004, Pages 797-808

  Scheid, Cheryl R ^a   Cao, Lu Cheng ^a   Honeyman, Thomas ^a   Jonassen, Julie A ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Cell death; Gene expression; Kidney; Mitochondria; Oxalate; Phospholipase A2; Review; Stone

Indexed keywords

ARACHIDONIC ACID; CERAMIDE; LIPID; LYSOPHOSPHATIDYLCHOLINE; OXALIC ACID; PHOSPHOLIPASE A2; REACTIVE OXYGEN METABOLITE; SPHINGOMYELIN PHOSPHODIESTERASE; OXALIC ACID DERIVATIVE;

APOPTOSIS; BINDING AFFINITY; CELL ACTIVITY; CELL ADHESION; CELL DAMAGE; CELL FUNCTION; CELL GROWTH; CELL MEMBRANE; CELL ORGANELLE; CELL PROLIFERATION; CELL VIABILITY; CRYSTALLIZATION; CYTOSOL; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; KIDNEY CELL; KINETICS; MACROMOLECULE; MITOCHONDRION; MOLECULAR MODEL; NEPHROLITHIASIS; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SURFACE PROPERTY; ANIMAL; CELL CULTURE; CYTOLOGY; DRUG EFFECT; KIDNEY; METABOLISM; PATHOPHYSIOLOGY;

ANIMALS; CELLS, CULTURED; CRYSTALLIZATION; CYTOSOL; HUMANS; KIDNEY; KIDNEY CALCULI; OXALATES;

EID: 2542481759     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1265     Document Type: Review

References (143)

1. Goodman H. O, R. Brommage, D. G. Assimos & R. P. Holmes: Genes in idiopathic calcium oxalate stone disease. World J Urol 15, 186-194 (1997)
2. Danpure C. J: Genetic disorders and urolithiasis. Urol Clin North Am 21, 287-299 (2000)
3. Wu W, D. E. Gerard & G. H. Nancollas: Nucleation at surfaces: the importance of interfacial energy. J Am Soc Nephrol 10 Suppl 14, S355-S358 (1999)
4. Ryall R. L: Glycosaminoglycans, proteins, and stone formation: adult themes and child's play. Ped Nephrol 10, 656-666 (1996)
5. Umekawa T, M. Iguchi, E. Konya, T. Yamate, N. Amasaki & T. Kurita: Localization and inhibitory activity of alpha(2)HS-glycoprotein in the kidney. Urol Res 27, 315-318 (1999)
6. Verkoelen C. F, B. G. Van Der Boom & J. C. Romijn: Identification of hyaluronan as a crystal-binding molecule at the surface of migrating and proliferating MDCK cells. Kid Int 58, 1045-1054 (2000)
7. Eguchi Y, M. Inoue, S. Iida, K. Matsuoka & S. Noda: Heparan sulfate (HS)/heparan sulfate proteoglycan (HSPG) and bikunin are up-regulated during calcium oxalate nephrolithiasis in rat kidney. Kurume Med J 49, 99-107 (2002)
8. Hess B: Tamm-Horsfall glycoprotein and calcium nephrolithiasis. Mineral Elect Metab 20, 393-398 (1994)
9. Gokhale J. A, P. A. Glenton & S. R. Khan: Characterization of Tamm-Horsfall protein in a rat nephrolithiasis model. J Urol 166, 1492-1497 (2001)
10. Kokot F. & J. Dulawa: Tamm-Horsfall protein updated. Nephron 85, 97-102 (2000)
11. Nakagawa Y, M. Ahmed, S. L. Hall, S. Deganello & F. L. Coe: Isolation from human calcium oxalate renal stones of nephrocalcin, a glycoprotein inhibitor of calcium oxalate crystal growth. Evidence that nephrocalcin from patients with calcium oxalate nephrolithiasis is deficient in g-carboxyglutamic acid. J Clin Invest 79, 1782-1787 (1987)
12. Nakagawa Y: Properties and function of nephrocalcin: mechanism of kidney stone inhibition or promotion. Keio J Med 46, 1-9 (1997)
13. Wesson J. A, E. M. Worcester, J. H. Wiessner, N. S. Mandel & J. G. Kleinman: Control of calcium oxalate crystal structure and cell adherence by urinary macromolecules. Kidney Int 53, 952-957 (1998)
14. Hoyer J. R: Uropontin in urinary calcium stone formation. Mineral Elect Metab 20, 385-392 (1994)
15. Wesson J. A, R. J. Johnson, M. Mazzali, A. M. Beshensky, S. Stietz, C. Giachelli, L. Liaw, C. E. Alpers, W. G. Couser, J. G. Kleinman & J. Hughes: Osteopontin is a critical inhibitor of calcium oxalate crystal formation and retention in renal tubules. J Am Soc Nephrol 14, 139-147 (2003)
16. Worcester E. M. & A. M. Beshensky: Osteopontin inhibits nucleation of calcium oxalate crystals. Ann NY Acad Sci 760, 375-377 (1995)
17. Grover P. K, S. C. Dogra, B. P. Davidson, A. M. Stapleton & R. L. Ryall: The prothrombin gene is expressed in the rat kidney: implications for urolithiasis research. Eur J Biochem 267, 61-67 (2000)
18. Atmani F, F. J. Opalko & S. R. Khan: Association of urinary macromolecules with calcium oxalate crystals induced in vitro in normal human and rat urine. Urol Res 24, 45- 50 (1996)
19. Atmani F, P. A. Glenton & S. R. Khan: Role of inter-alpha-inhibitor and its related proteins in experimentally induced calcium oxalate urolithiasis. Localization of proteins and expression of bikunin gene in the rat kidney. Urol Res 27, 63-67 (1999)
20. Médétognon-Benissan J, S. Tardivel, C. Hennequin, M. Daudon, T. Drueke & B. Lacour: Inhibitory effect of bikunin on calcium oxalate crystallization in vitro and urinary bikunin decrease in renal stone formers. Urol Res 27, 69-75 (1999)
21. Dean C, J. Kanellos, H. Pham, M. Gomes, A. Oates, P. Grover & R. Ryall: Effects of inter-alpha-inhibitor and several of its derivatives on calcium oxalate crystallization in vitro. Clin Sci 98, 471-480 (2000)
22. Pillay S. N, J. R. Asplin & F. L. Coe: Evidence that calgranulin is produced by kidney cells and is an inhibitor of calcium oxalate crystallization. Am J Physiol 275, F255-F261 (1998)
23. Tsujihata M, O. Miyake, K. Yoshimura, K. I. Kakimoto, S. Takahara & A. Okuyama: Fibronectin as a potent inhibitor of calcium oxalate urolithiasis. J Urol 164, 1718-1723 (2000)
24. Tardivel S, J. Medetognon, C. Randoux, M. Kebede, T. Drucke, M. Daudon, C. Hennequin & B. Lacour: Alpha-1-microglobulin inhibitory effect on calcium oxalate crystallization in vitro and decreased urinary concentration in calcium oxalate stone formers. Urol Res 27, 243-249 (1999)
25. Resnick M. I, D. Munday & W. H. Boyce: Urinary beta 2-microglobulin excretion and renal lithiasis. Invest Urol 18, 137-138 (1980)
26. Cerini C, S. Geider, B. Dussol, C. Hennequin, M. Daudon, S. Veesler, S. Nitsche, R. Boistelle, P. Berthezene, P. Dupuy, A. Vazi, Y. Berland, J. C. Dagorn & J. M. Verdier: Nucleation of calcium oxalate crystals by albumin: involvement in the prevention of stone formation. Kidney Int 55, 1776-1786 (1999)
27. Lanzalaco A. C, R. P. Singh, S. A. Smesko, G. H. Nancollas, G. Sufrin, M. Binette & J. P. Binette: The influence of urinary macromolecules on calcium oxalate monohydrate crystal growth. J Urol 139, 190-195 (1988)
28. Worcester E. M: Inhibitors of stone formation. Semin Nephrol 16, 474-486 (1996)
29. Coe F. L. & J. H. Parks: Does a failure of crystal inhibition cause calcium renal stones? Nephron 90, 361-364 (2002)
30. Nancollas G. H, S. A. Smesko, A. A. Campbell, C. F. Richardson, M. Johnsson, R. A. Iadiccico, J. P. Binette & M. Binette,: Physical chemical studies of calcium oxalate crystallization. Am J Kidney Dis 17, 392-395 (1991)
31. Khan S. R, P. N. Shevock & R. L. Hackett: Acute hyperoxaluria, renal injury and calcium oxalate urolithiasis. J Urol 147, 226-230 (1992)
32. Khan S. R & R. L. Hackett: Role of organic matrix in urinary stone formation: an ultrastructural study of crystal matrix interface of calcium oxalate monohydrate stones. J Urol 150, 239-245 (1993)
33. Khan S. R, S. A. Maslamani, F. Atmani, P. A. Glenton, F. J. Opalko, S. Thamilselvan & C. Hammett-Stabler: Membranes and their constituents as promoters of calcium oxalate crystal formation in human urine. Calcif Tissue Int 66, 90-96 (2000)
34. Wu W, H. Zhuang & G. H. Nancollas: Heterogeneous nucleation of calcium phosphates on solid surfaces in aqueous solution. J Biomed Mater Res 35, 93-99 (1997)
35. McKee M. D, A. Nanci & S. R. Khan: Ultrastructural immunodetection of osteopontin and osteocalcin as major matrix components of renal calculi. J Bone Miner Res 10, 1913-1929 (1995)
36. Atmani F, P. A. Glenton & S. R. Khan: Identification of proteins extracted from calcium oxalate and calcium phosphate crystals induced in the urine of healthy and stone forming subjects. Urol Res 26, 201-207 (1998)
37. Tawada T, K. Fujita, T. Sakakura, T. Shibutani, T. Nagata, M. Iguchi & K. Kohri: Distribution of osteopontin and calprotectin as matrix protein in calcium-containing stone. Urol Res 27, 238-242 (1999)
38. Ryall R, D. E. Fleming, P. K. Grover, M. Chauvet, C. J. Dean & V. R. Marshall: The whole truth: intracrystalline proteins and calcium oxalate kidney stones. Molec Urol 4, 391-402 (2000)
39. Kok D. J: Crystallization and stone formation inside the nephron. Scanning Microsc 10, 471-484 (1996)
40. Kok D. J: Clinical implications of physicochemistry of stone formation. Endocrinol Metab Clin North Am 31, 855-867 (2002)
41. Jiang X. J, T. Feng, L. S. Chang, X T. Kong, G. Wang, Z. W. Zhang & Y L. Guo: Expression of osteopontin mRNA in normal and stone-forming rat kidney. Urol Res 26, 389-394 (1998)
42. Khan S. R, J. M. Johnson, A. B. Peck, J. G. Cornelius & P. A. Glenton: Expression of osteopontin in rat kidneys: induction during ethylene glycol induced calcium oxalate nephrolithiasis. J Urol 168, 1173-1181 (2002)
43. Moriyama M. T, P. A. Glenton & S. R. Khan: Expression of inter-alpha inhibitor related proteins in kidneys and urine of hyperoxaluric rats. J Urol 165, 1687-1692 (2001)
44. Iida S, J. Miyajima, K. Suzuki, K. Matsuoka, M. Inoue & S. Noda: Expression of heparan sulfate proteoglycan mRNA in rat kidneys during calcium oxalate nephrolithiasis. Urol Res 25, 361-364 (1997)
45. Asplin J. R, J. H. Parks, M. S. Chen, J. C. Lieske, F. G. Toback, S. N. Pillay, Y. Nakagawa & F. L. Coe: Reduced crystallization inhibition by urine from men with nephrolithiasis. Kidney Int 56, 1505-1516 (1999)
46. Tiselius H. G, A. Hallin & B. Lindback: Crystallisation properties in stone forming and normal subjects' urine diluted using a standardised procedure to match the composition of urine in the distal part of the distal tubule and the middle part of the collecting duct. Urol Res 29, 75-82 (2001)
47. Jonassen J. A, L-C. Cao, T. W. Honeyman & C. R. Scheid: Mechanisms mediating oxalate-induced alterations in renal cell functions. Crit Rev Euk Gene Exp 13, 55-72 (2003)
48. Grases F, L. Masarova, O. Sohnel & A. Costa-Bauza: Agglomeration of calcium oxalate monohydrate in synthetic urine. Br J Urol 70, 240-246 (1992)
49. Kok D. J. & S. E. Papapoulos: Physicochemical considerations in the development and prevention of calcium oxalate urolithiasis. Bone Miner Res 20, 1-15 (1993)
50. Riese R. J, N. S. Mandel, J H. Wiessner, G. S. Mandel, C. G. Becker & J. G. Kleinman: Cell polarity and calcium oxalate crystal adherence to cultured collecting duct cells. Am J Physiol 262, F177-F184 (1992)
51. Mandel N: Crystal-membrane interaction in kidney stone disease. J Am Soc Nephrol 5, S37-S45 (1994)
52. Wiessner J. H, A. T. Hasegawa, L. Y. Hung & N. S. Mandel: Oxalate-induced exposure of phosphatidylserine on the surface of renal epithelial cells in culture. J Am Soc Nephrol 10, S441-S445 (1999)
53. Wiessner J. H, A. T. Hasegawa, L. Y. Hung, G. S. Mandel & N. S. Mandel: Mechanisms of calcium oxalate crystal attachment to injured renal collecting duct cells. Kid Int 59, 637-644 (2001)
54. Bigelow M. W, J. H. Wiessner, J. G. Kleinman & N. S. Mandel: Surface exposure of phosphatidylserine increases calcium oxalate crystal attachment to IMCD cells. Amer J Physiol 272, F55-62 (1997)
55. Lieske J. C. & F. G. Toback: Regulation of renal epithelial cell endocytosis of calcium oxalate monohydrate crystals. Am J Physiol 264, F800-F807 (1993)
56. Lieske J. C, R. Leonard, H. Swift & F. G. Toback: Adhesion of calcium oxalate monohydrate crystals to anionic sites on the surface of renal epithelial cells. Am J Physiol 270, F192-F199 (1996)
57. Verkoelen C. F, B. G. van der Boom, A. B. Houtsmuller, F. H. Schroder & J. C. Romijn: Increased calcium oxalate monohydrate crystal binding to injured renal tubular epithelial cells in culture. Am J Physiol 274, F958-F965 (1998)
58. Verhulst A, M. Asselman, V. P. Persy, M. S. Schepers, M. F. Helbert, C. F. Verkoelen, M. E. de Broe: Crystal retention capacity of cells in the human nephron: involvement of CD44 and its ligands hyaluronic acid and osteopontin in the transition of a crystal binding into a nonadherent epithelium. J Am Soc Nephrol 13, 107-115 (2003)
59. Koul H, L. Kennington, G. Nair, T. Honeyman, M. Menon & C. Scheid: Oxalate-induced initiation of DNA synthesis in LLC-PK1 cells, a line of renal epithelial cells. Biochem Biophys Res Commun 205, 1632-1637 (1994)
60. Scheid C. R, H. K. Koul, L. Kennington, W. A. Hill, J. Luber-Narod, J. Jonassen, T. Honeyman & M. Menon: Oxalate-induced damage to renal tubular cells: a review. Scanning Microsc 9, 1097-1107 (1995)
61. Scheid C. R, H. Koul, W. A. Hill, J. Luber-Narod, J. Jonassen, T. Honeyman, L. Kennington, R. Kohli, J. Hodapp, P. Ayvazian & M. Menon: Oxalate toxicity in LLC-PK1 cells, a line of renal epithelial cells. J Urol 155, 1112-1116 (1996)
62. Scheid C, H. Koul, W. A. Hill, J. Luber-Narod, L. Kennington, T. Honeyman, J. Jonassen & M. Menon: Oxalate toxicity in LLC-PK1 cells: role of free radicals. Kid Int 49, 413-419 (1996)
63. Hackett R. L, P. N. Shevock & S. R. Khan: Madin-Darby canine kidney cells are injured by exposure to oxalate and to calcium oxalate crystals. Urol Res 22, 197-204 (1994)
64. Thamilselvan S & S. R. Khan: Oxalate and calcium oxalate crystals are injurious to renal epithelial cells: results of in vivo and in vitro studies. J Nephrol 11, 66-69 (1998)
65. Cao L-C, J. Jonassen, T. W. Honeyman & C. Scheid: Oxalate-induced redistribution of phosphatidylserine in renal epithelial cells: implications for kidney stone disease. Am J Nephrol 21, 69-71 (2001)
66. Finlayson B. & F. Reid: The expectation of free and fixed particles in urinary stone disease. Invest Urol 15, 442-448 (1978)
67. Kok D. J. & S. R. Khan: Calcium oxalate nephrolithiasis, a free or fixed particle disease. Kidney Int 46, 847-854 (1994)
68. Verkleij A. J. & J. A. Post: Membrane phospholipid asymmetry and signal transduction. J Membr Biol 178, 1-10 (2000)
69. Sambrano G. R. & D. Steinberg: Recognition of oxidatively damaged and apoptotic cells by an oxidized low density lipoprotein receptor on mouse peritoneal macrophages: role of membrane phosphatidylserine. Proc Natl Acad Sci USA 92, 1396-1400 (1995)
70. Nancollas G. H, A. Tsortos & A. Zieba: The nucleation and growth of calcium phosphate crystals at protein and phosphatidylserine liposome surfaces. Scanning Microsc 10, 499-507 (1996)
71. Verkoelen C. F, B. G. van der Boom, D. J. Kok & J. C. Romijn: Sialic acid and crystal binding. Kid Int 57, 1072-1082 (2000)
72. Lieske J. C, F. G. Toback & S. Deganello: Sialic acid-containing glycoproteins on renal cells determine nucleation of calcium oxalate dihydrate crystals. Kidney Int 60, 1784-1791 (2001)
73. Goswami A, P. C. Singhal, J. D. Wagner, M. Urivetzky, E. Valderrama & A D. Smith: Matrix modulates uptake of calcium oxalate crystals and cell growth of renal epithelial cells. J Urol 153, 206-211 (1995)
74. Sorokina E. A & J. G. Kleinman: Cloning and preliminary characterization of a calcium-binding protein closely related to nucleolin on the apical surface of inner medullary collecting duct cells. J Biol Chem 274, 27491-27496 (1999)
75. Khan S. R: Calcium oxalate crystal interaction with renal tubular epithelium, mechanism of crystal adhesion and its impact on stone development. Urol Res 23, 71-79 (1995)
76. Lieske J. C, M. M. Walsh-Reitz & F. G. Toback: Calcium oxalate monohydrate crystals are endocytosed by renal epithelial cells and induce proliferation. Am J Physiol 262, F622-630 (1992)
77. Kohjimoto Y, S. Ebisuno, M. Tamura & T. Ohkawa: Interactions between calcium oxalate monohydrate crystals and Madin-Darby canine kidney cells: endocytosis and cell proliferation. Urol Res 24, 193-199 (1996)
78. Campos A. H. & N. Schor: Mechanisms involved in calcium oxalate endocytosis by Madin-Darby canine kidney cells. Braz J Med Biol Res 33, 111-118 (2000)
79. Cheung H. S, M. T. Story & D. J. McCarty: Mitogenic effects of hydroxyapatite and calcium pyrophosphate dihydrate crystals on cultured mammalian cells. Arthritis Rheum 27, 668-674 (1984)
80. Cheung H. S. & D. J. McCarty: Mitogenesis induced by calcium containing crystals. Role of intracellular dissolution. Exp Cell Res 157, 63-70 (1985)
81. Hammes M. S, J. C. Lieske, S. Pawar, B. H. Spargo & F. G. Toback: Calcium oxalate monohydrate crystals stimulate gene expression in renal epithelial cells. Kid Int 48, 501-509 (1995)
82. Koul H, L. Kennington, T. Honeyman, J. Jonassen, M. Menon & C. Scheid: Activation of c-myc gene mediates the mitogenic effects of oxalate in LLC-PK1 cells, a line of renal epithelial cells. Kid Int 50, 1525-1530 (1996)
83. Jonassen J. A, R. Cooney, L. Kennington, K. Gravel, T. Honeyman & C. R. Scheid: Oxalate-induced changes in the viability and growth of human renal epithelial cells. J Am Soc Nephrol 10, S446-S451 (1999)
84. Dennis E. A: The growing phospholipase A2 superfamily of signal transduction enzymes. Trends Biochem Sci 22, 1-2 (1997)
85. Schnellman R. G, X. Yang & J. B. Carrick: Arachidonic acid release in renal proximal tubule cell injuries and death. J Biochem Toxicol 9, 211-217 (1994)
86. Edelstein C. L, H. Ling & R. W. Schrier: The nature of renal cell injury. Kidney Int 51, 1341-1351 (1997)
87. Shankland S. J: New insights into the pathogenesis of membranous nephropathy. Kidney Int 57, 1204-1205 (2000)
88. Baggio B. & G. Gambaro: Abnormal arachidonic acid content of membrane phospholipids - the unifying hypothesis for the genesis of hypercalciuria and hyperoxaluria in idiopathic calcium nephrolithiasis. Nephrol Dial Transplant 14, 553-555 (1999)
89. Baggio B, A. Budakovic, M. A. Nassuato, G. Vezzoli, E. Manzato, G. Luisetto & M. Zaninotto: Plasma phospholipid arachidonic acid content and calcium metabolism in idiopathic calcium nephrolithiasis. Kidney Int 58, 1278-1284 (2000)
90. Kohjimoto Y, L. Kennington, C. R. Scheid & T. W. Honeyman: Role of phospholipase A2 in the cytotoxic effects of oxalate in cultured renal epithelial cells. Kid Int 56, 1432-1441 (1999)
91. 2 mediates immediate early genes in cultured renal epithelial cells: possible role of lysophospholipid. Kid Int 58, 638-646 (2000)
92. Dixon R. J. & N. J. Brunskill: Lysophosphatidic acid-induced proliferation in opossum kidney proximal tubular cells: role of PI3-kinase and ERK. Kidney Int 56, 2064-2075 (1999)
93. 2+ influx, enhanced DNA synthesis and cytotoxicity in cultured vascular smooth muscle cells. Atherosclerosis 112, 69-76 (1995)
94. Levine J. S, J. S. Koh, V. Triaca & W. Lieberthal: Lysophosphatidic acid: a novel growth and survival factor for renal proximal tubular cells. Am J Physiol 273, F575-F585 (1997)
95. Kohri K, S. Nomura, Y. Kitamura, T. Nagata, K. Yoshioka, M. Iguchi, T. Yamate, T. Umekawa, Y. Suzuki, H. Sinohara & T. Kurita: Structure and expression of the mRNA encoding urinary stone protein (osteopontin). J Biol Chem 268, 15180-15184 (1993)
96. Umekawa T, K. Kohri, T. Kurita, S. Hirota, S. Nomura & Y. Kitamura: Expression of osteopontin messenger RNA in the rat kidney on experimental model of renal stone disease. Biochem Molec Biol Int 35, 223-230 (1995)
97. Lieske J. C, M S. Hammes, J. R. Hoyer & F. G. Toback: Renal cell osteopontin production is stimulated by calcium oxalate monohydrate crystals. Kidney Int 51, 679-686 (1997)
98. Yasui T, K. Fujita, S. Sasaki, M. Sato, M. Sugimoto, S. Hirota, Y. Kitamura, S. Nomura & K. Kohri: Expression of bone matrix proteins in urolithiasis model rats. Urol Res 27, 255-261 (1999)
99. Marengo S. R, D. H. Chen, H. L. Kaung, M. I. Resnick & L. Yang: Decreased renal expression of the putative calcium oxalate inhibitor Tamm-Horsfall protein in the ethylene glycol rat model of calcium oxalate urolithiasis. J Urol 167, 2192-2197 (2002)
100. Katsuma S, S. Shiojima, A. Hirasawa, K. Takagaki, Y. Kaminishi, M. Koba, Y. Hagidai, M. Murai, T. Ohgi, J. Yano & G. Tsujimoto: Global analysis of differentially expressed genes during progression of calcium oxalate nephrolithiasis. Biochem Biophys Res Commun 296, 544-552 (2002)
101. Scheid C, T. Honeyman, Y. Kohjimoto, L-C. Cao & J. Jonassen: Oxalate-induced changes in renal epithelial cell function: role in stone disease. Molec Urol 4, 371-382 (2000)
102. Iida S, A. B. Peck, K. J. Byer & S. R. Khan: Expression of bikunin mRNA in renal epithelial cells after oxalate exposure. J Urol 162, 1480-1486 (1999)
103. Kume N, M. I. Cybulsky & M. A. Gimbrone Jr: Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest 90, 1138-1144 (1992)
104. Kume N. & M. A. Gimbrone Jr: Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells. J Clin Invest 93, 907-911 (1994)
105. Zhu Y, JH-C Lin, H-L. Liao, L. Verna & M. B. Stemerman: Activation of ICAM-1 promoter by lysophosphatidylcholine: possible involvement of protein tyrosine kinases. Biochim Biophys Acta 1345, 93-98 (1997)
106. Nishi E, N. Kume, H. Ochi, H. Moriwaki, Y. Wakatsuki, S. Higashiyama, N. Taniguchi & T. Kita: Lysophosphatidylcholine increases expression of heparin-binding epidermal growth factor-like growth factor in human T lymphocytes. Circ Res 80, 638-644 (1997)
107. Rong J. X, J. W. Berman, M. B. Taubman & E. A. Fisher: Lysophosphatidylcholine stimulates monocyte chemoattractant protein-1 gene expression in rat aortic smooth muscle cells. Arterioscler Thromb Vasc Biol 22, 1617-1623 (2002)
108. Umekawa T, N. Chegini & S. R. Khan: Oxalate ions and calcium oxalate crystals stimulate MCP-1 expression by renal epithelial cells. Kidney Int 61, 105-112 (2002)
109. Viedt C. & S. R. Orth: Monocyte chemoattractant protein-1 (MCP-1) in the kidney: does it more than simply attract monocytes? Nephrol Dial Transplant 17, 2043-2047 (2002)
110. de Water R, C. Noordermeer, A. B. Houtsmuller, A. L. Nigg, T. Stijnen, F. H. Schroder & D. J. Kok: Role of macrophages in nephrolithiasis in rats: an analysis of the renal interstitium. Am J Kidney Dis 36, 615-625 (2000)
111. Fang X, S. Gibson, M. Flowers, T. Frui, R. C. Bast Jr & G. B. Mills: Lysophosphatidycholine stimulate activator protein 1 and the c-Jun N-terminal kinase activity. J Biol Chem 272, 13683-13689 (1997)
112. Ueno Y, N. Kume, S. Miyamoto, M. Morimoto, H. Kataoka, H. Ochi, E. Nishi, H. Moriwaki, M. Minami, N. Hashimoto & T. Kita: Lysophosphatidylcholine phosphorylates CREB and activates the jun2TRE site of c-jun promoter in vascular endothelial cells. FEBS Lett 457, 241-245 (1999)
113. Yamakawa T, S. Eguchi, Y. Yamakawa, E. D. Motley, K. Numaguchi, H. Utsunomiya & T. Inagami: Lysophosphatidylcholine stimulates MAP kinase activity in rat vascular smooth muscle cells. Hypertens 31, 248-253 (1998)
114. Cieslik K, A. Zembowicz, J.-L. Tang & K. K. Wu: Transcriptional regulation of endothelial nitric-oxide synthase by lysophosphatidylcholine. J Biol Chem 273, 14885-14890 (1998)
115. Morimoto M, N. Kume, S. Miyamoto, Y. Ueno, H. Kataoka, M. Minami, K. Hayashida, N. Hashimoto & T. Kita: Lysophosphatidylcholine induces early growth response factor-1 expression and activates the core promoter of PDGF-A chain in vascular endothelial cells. Arterioscler Thromb Vasc Biol 21, 771-776 (2001)
116. Masamune A, Y. Sakai, M. Yoshida, A. Satoh, K. Satoh & T. Shimosegawa: Lysophosphatidylcholine activates transcription factor NF-kappaB and AP-1 in AR42J cells. Dig Dis Sci 46, 1871-1881 (2001)
117. Miller C, L. Kennington, R. Cooney, T. Honeyman, Y. Kohjimoto, L-C. Cao, J. Pullman, J. Jonassen & C R. Scheid: Oxalate toxicity in renal epithelial cells: characteristics of apoptosis and necrosis. Toxicol Appl Pharm 162, 132-141 (2000)
118. Cao L-C, T. Honeyman, J. Jonassen & C. Scheid: Oxalate-induced ceramide accumulation in Madin-Darby canine kidney and LLC-PK1 cells. Kidney Int 57, 2403-2411 (2000)
119. Kolesnick R. N & M. Kronke: Regulation of ceramide production and apoptosis. Annu Rev Physiol 60, 643-665 (1998)
120. Jayadev S, C. M. Linardic & Y. A. Hannun: Identification of arachidonic acid as a mediator of sphingomyelin hydrolysis in response to tumor necrosis factor alpha. J Biol Chem 269, 5757-5763 (1994)
121. Riboni L, P. Viani, R. Bassi, A. Prinetti & G. Tettamanti: The role of sphingolipids in the process of signal transduction. Prog Lipid Res 36, 153-195 (1997)
122. Hashizume T, K. Kitatani, T. Kageura, M. Hayama, S. Akiba & T. Sato: Ceramide enhances susceptibility of membrane phospholipids to phospholipase A2 through modification of lipid organization in platelet membranes. Biol Pharm Bull 22, 1275-1278 (1999)
123. Hannun Y. A: The sphingomyelin cycle and the second messenger function of ceramide. J Biol Chem 269, 3125-3128 (1994)
124. Khan S. R, K. J. Byer, S. Thamilselvan, R. L. Hackett, W. T. McCormack, N. A. Benson, K. L. Vaughn & G. W. Erdos: Crystal-cell interaction and apoptosis in oxalate-associated injury of renal epithelial cells. J Am Soc Nephrol 10, S457-S463 (1999)
125. Sarica K, F. Yagci, K. Bakir, A. Erbagci, S. Erturhan & R. Ucak: Renal tubular injury induced by hyperoxaluria: evaluation of apoptotic changes. Urol Res 29, 34-37 (2001)
126. Crompton M: The mitochondrial permeability transition pore and its role in cell death. Biochem J 341, 233-249 (1999)
127. Kurien T. B. & R. Selvam: Induction of lipid peroxidation in calcium oxalate stone formation. Indian J Exp Biol 27, 450-453 (1989)
128. Muthukumar A. & R. Selvam: Renal injury mediated calcium oxalate nephrolithiasis: role of lipid peroxidation. Renal Fail 19, 401-408 (1997)
129. Thamilselvan S, R. L. Hackett & S. R. Khan: Lipid peroxidation in ethylene glycol induced hyperoxaluria and calcium oxalate nephrolithiasis. J Urol 157, 1059-1063 (1997)
130. Selvam R: Calcium oxalate stone disease: role of lipid peroxidation and antioxidants. Urol Res 30, 35-47 (2002)
131. Muthukumar A. & R. Selvam: Role of glutathione on renal mitochondrial status in hyperoxaluria. Mol Cell Biochem 185, 77-84 (1998)
132. Huang H. S, M. C. Ma, J. Chen & C. F. Chen: Changes in the oxidant-antioxidant balance in the kidney of rats with nephrolithiasis induced by ethylene glycol. J Urol 167, 2584-2593 (2002)
133. Khand F. D, M. P. Gordge, W. G. Robertson, A. A. Noronha-Dutra & J. S. Hothersall: Mitochondrial superoxide production during oxalate-mediated oxidative stress in renal epithelial cells. Free Radic Biol Med 32, 1339-1350 (2002)
134. Thamilselvan S, K. J. Byer, R. L. Hackett & S. R. Khan: Free radical scavengers, catalase and superoxide dismutase provide protection from oxalate-associated injury to LLC-PK1 and MDCK cells. J Urol 164, 224-229 (2000)
135. Thamilselvan S, S. R. Khan & M. Menon: Oxalate and calcium oxalate mediated free radical toxicity in renal epithelial cells: effect of antioxidants. Urol Res 31, 3-9 (2002)
136. Hsieh N, C. H. Shih, H. Y. Chen, M. C. Wu, W. C. Chen & C. W. Li: Effects of Tamm-Horsfall protein on the protection of MCDK cells from oxalate induced free radical injury. Urol Res 31, 10-16 (2003)
137. Ruvolo P. P, X. Deng, B. K. Carr & W. S. May: A functional role for mitochondrial protein kinase Calpha in Bcl2 phosphorylation and suppression of apoptosis. J Biol Chem 273, 25436-25442 (1998)
138. Cao L-C, T. W. Honeyman & C. R. Scheid. Role of mitochondria in oxalate actions on renal cells. In: Eurolithiasis. 9th European Symposium of Urolithiasis. pp. 110-111. Eds: Kok D. J., Romijn H. C., Verhagen C. M. S., Verkoelen C. F., Shaker Publishing, Maastricht, the Netherlands. (2001)
139. Strzelecki T, B. R. McGraw, C. R. Scheid & M. Menon: Effect of oxalate on function of kidney mitochondria. J Urol 141, 423-427 (1989)
140. Loeffler M. & G. Kroemer: The mitochondrion in cell death control: certainties and incognita. Exp Cell Res 256, 19-26 (2000)
141. Petronelli V, D. Penzo, L. Scorrano, P. Bernardi & F. Di Lisa: The mitochondrial permeability transition, release of cytochrome c and cell death. Correlation with the duration of pore openings in situ. J Biol Chem 276, 12030-12034 (2001)
142. Khan S. R, F. Atmani, P. Glenton, Z. Hou, D. R. Talham & M. Khurshid: Lipids and membranes in the organic matrix of urinary calcific crystals and stones. Calcif Tissue Int 59, 357-365 (1996)
143. Evan A. P, J. E. Lingeman, F. L. Coe, J. H. Parks, S. B. Bledsoe, Y. Shao, A. J. Sommer, R. F. Paterson, R. L. Kuo & M. Grynpas: Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest 111, 607-616 (2003)